Clinical Trials Browser

Phase 2 × Hydrogen × Genitourinary × Clear all

NCT03933670 2026-02-18

Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance

Phase 2 Recruiting

Prostatic Neoplasms